China advances biotech racebiotech race for Parkinson’s treatments
China is pushing ahead in a biotech competition to develop better treatments for Parkinson’s disease, according to a conference in Beijing on May 9 hosted at People’s Daily headquarters.
The coverage says Chinese researchers and companies are aiming to move faster than the United States in a field with major medical and commercial stakes, making the race important for global health innovation.
- Parkinson’s disease was first described in 1817 by British doctor James Parkinson.
- China has sharply expanded its share of global biomedical research in recent years.
- Biotech patents can be crucial because drug development often takes many years and very large investments.
